| A D N I |
| Alzheimer's Disease |
| Neuroimaging Initiative |
What is ADNI?
The major goals of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) are to:
1) Develop improved methods, which will lead to uniform standards for acquiring longitudinal, multi-site MRI and PET data on patients with Alzheimer’s disease (AD), mild cognitive impairment (MCI), and elderly controls.
2) Acquire a generally accessible data repository, which describes longitudinal changes in brain structure and metabolism. In parallel, acquire clinical, cognitive and biomarker data for validation of imaging surrogates.
3) Determine those methods, which provide maximum power to determine treatment effects in trials involving these patient groups. A team of investigators with considerable experience in AD clinical trials, MRI, PET, biomarkers and informatics has been assembled. Read More
|
|
ADNI Frequently Asked Questions
|
Downloadable
ADNI Pamplet (PDF)
|
| Research Cores |
Use of the information and materials on this server is subject to the terms and conditions contained in the Terms of Use and Privacy Statement. By using this web site, you agree to these terms and conditions. Materials on this web site are for informational purposes and are not a substitute for consulting your personal physician.
